© 1999 by European Society of Cardiology
Copyright © 1999, European Society of Cardiology
Benzocaine enhances and inhibits the K+ current through a human cardiac cloned channel (Kv1.5)
aDepartment of Pharmacology, School of Medicine, Universidad Complutense, 28040-Madrid, Spain
bLaboratory for Molecular Biophysics, Physiology and Pharmacology, Universitaire Instelling Antwerpen, Universiteitsplein 1, B-2610 Wilrijk, Belgium
edelpon{at}eucmax.sim.ucm.es
* Corresponding author. Tel.: +34-91-394-1474; fax: +34-91-394-1470
Objective: The aim of this study was to analyze the effects of a neutral local anaesthetic, benzocaine, on a cardiac K+ channel cloned from human ventricle. Methods: Experiments were performed on hKv1.5 channels stably expressed on mouse cells using the whole-cell configuration of the patch clamp technique. Results: At 10 nM, benzocaine increased the current amplitude ("agonist effect") by shifting the activation curve 8.4±2.7 mV in the negative direction, and slowed the time course of tail current decline. In contrast, benzocaine (100–700 µM) inhibited hKv1.5 currents (KD=901±81 µM), modified the voltage-dependence of channel activation, which became biphasic, and accelerated the channel deactivation. Extracellular K+ concentration ([K+]o) also affected the channel gating. At 140 mM [K+]o, the time course of tail currents deactivation was significantly accelerated, whereas at 0 mM [K+]o, it was slowed. At both [K+]o the activation curve became biphasic. Benzocaine accelerated the tail current decay at 0 mM but not at 140 mM [K+]o. The reduction in the permeation of K+ through the pore did not modify the blocking effects of micromolar concentrations of benzocaine, but suppressed the agonist effect observed at nanomolar concentrations. Conclusions: All these results suggest that benzocaine blocks and modifies the voltage- and time-dependent properties of hKv1.5 channels, binding to an extracellular and to an intracellular site at the channel level. Moreover, both sites are related to each other and can also interact with K+.
KEYWORDS Benzocaine; Drug–channel interactions; Local anesthetic; K+ channels; Mouse
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon Pharmacology of cardiac potassium channels Cardiovasc Res, April 1, 2004; 62(1): 9 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Caballero, I. Moreno, T. Gonzalez, C. Valenzuela, J. Tamargo, and E. Delpon Putative binding sites for benzocaine on a human cardiac cloned channel (Kv1.5) Cardiovasc Res, October 1, 2002; 56(1): 104 - 117. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nattel, D. M. Roden, and D. Escande A spotlight on electrophysiological remodeling and the molecular biology of ion channels Cardiovasc Res, May 1, 1999; 42(2): 267 - 269. [Full Text] [PDF]
|
|